Product information

Current status:

Cancelled Post Market

Current status date:

2018-11-15

Original market date: ^{See footnote 1}

1998-05-19

Lot number: ^{See footnote 2}

662274

Expiry date: ^{See footnote 2}

2017-02-28

Product name:

METHOXISAL-C 1/2

DIN:

01966375 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Narcotic (CDSA I)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:08.08  ,  12:20.04 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N02AA59 CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS

Active ingredient group (AIG) number:^{See footnote5}

0301256001

Risk Management Plans ^{See footnote 7}

A Canadian Specific Opioid targeted Risk Management Plan (CSO-tRMP) for this product was submitted.